ViviCells Net Income Applicable To Common Shares from 2010 to 2026

VCII Stock  USD 0.0001  0.00  0.000003%   
ViviCells International's Net Loss is increasing with slightly volatile movements from year to year. Net Loss is predicted to flatten to about -17.4 K. Net Loss is the net income that remains after preferred dividends have been deducted, available to common shareholders. View All Fundamentals
 
Net Loss  
First Reported
2010-12-31
Previous Quarter
-16.6 K
Current Value
-17.4 K
Quarterly Volatility
73.3 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check ViviCells International financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among ViviCells International's main balance sheet or income statement drivers, such as Discontinued Operations of 0.0, Interest Expense of 0.0 or Selling General Administrative of 820 K, as well as many indicators such as Price To Sales Ratio of 17.1 K, Dividend Yield of 0.0 or PTB Ratio of 6.49. ViviCells financial statements analysis is a perfect complement when working with ViviCells International Valuation or Volatility modules.
  
Build AI portfolio with ViviCells Stock
Check out the analysis of ViviCells International Correlation against competitors.
For more detail on how to invest in ViviCells Stock please use our How to Invest in ViviCells International guide.

Latest ViviCells International's Net Income Applicable To Common Shares Growth Pattern

Below is the plot of the Net Income Applicable To Common Shares of ViviCells International over the last few years. It is the net income that remains after preferred dividends have been deducted, available to common shareholders. ViviCells International's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in ViviCells International's overall financial position and show how it may be relating to other accounts over time.
Net Income Applicable To Common Shares10 Years Trend
Slightly volatile
   Net Income Applicable To Common Shares   
       Timeline  

ViviCells Net Income Applicable To Common Shares Regression Statistics

Arithmetic Mean(32,530)
Coefficient Of Variation(225.23)
Mean Deviation33,446
Median(14,439)
Standard Deviation73,266
Sample Variance5.4B
Range302.4K
R-Value0.40
Mean Square Error4.8B
R-Squared0.16
Significance0.11
Slope5,833
Total Sum of Squares85.9B

ViviCells Net Income Applicable To Common Shares History

2026-17.4 K
2025-16.6 K
2011-14.4 K
2010-316.8 K

About ViviCells International Financial Statements

Investors use fundamental indicators, such as ViviCells International's Net Income Applicable To Common Shares, to determine how well the company is positioned to perform in the future. Although ViviCells International's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Net Loss-16.6 K-17.4 K

Currently Active Assets on Macroaxis

When determining whether ViviCells International offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of ViviCells International's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Vivicells International Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Vivicells International Stock:
Check out the analysis of ViviCells International Correlation against competitors.
For more detail on how to invest in ViviCells Stock please use our How to Invest in ViviCells International guide.
You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Is Independent Power and Renewable Electricity Producers space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ViviCells International. If investors know ViviCells will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ViviCells International listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Revenue Growth
(0.27)
The market value of ViviCells International is measured differently than its book value, which is the value of ViviCells that is recorded on the company's balance sheet. Investors also form their own opinion of ViviCells International's value that differs from its market value or its book value, called intrinsic value, which is ViviCells International's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ViviCells International's market value can be influenced by many factors that don't directly affect ViviCells International's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ViviCells International's value and its price as these two are different measures arrived at by different means. Investors typically determine if ViviCells International is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ViviCells International's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.